Industry News
Statistical Image Analysis Method Offers Automatic Mitotic Cell Detection For Breast Cancer Diagnosis
Nov 14, 2012
Scientists have developed a statistical image analysis method which can assist in the grading of breast cancer by automatically segmenting tumour regions and detecting dividing cells in tissue samples... Read More
News From The Annals Of Family Medicine: November/December 2012
Nov 14, 2012
52,000 More Primary Care Physicians Needed by 2025 to Meet Anticipated Demand Researchers project the United States will need 52,000 additional primary care physicians by 2025 - a 25 percent increase in the current workforce - to address the expected increases in demand due to population growth, aging, and insurance expansion following passage of the Affordable Care Act... Read More
How A Substance Made By The Body To Promote Inflammation Can Cause An Aggressive Form Of Leukemia
Nov 14, 2012
A hormone-like substance produced by the body to promote inflammation can cause an aggressive form of leukemia when present at high levels, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James)... Read More
Asian Women With Certain Gene Variations At Greater Risk For Lung Cancer
Nov 14, 2012
An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, especially Asian women, may be associated with certain unique inherited genetic characteristics that distinguishes it from lung cancer in smokers... Read More
System Combining Nanotechnology And NMR Detects Particles Shed By Brain Tumors In Bloodstream
Nov 14, 2012
A novel miniature diagnostic platform using nuclear magnetic resonance (NMR) technology is capable of detecting minuscule cell particles known as microvesicles in a drop of blood. Microvesicles shed by cancer cells are even more numerous than those released by normal cells, so detecting them could prove a simple means for diagnosing cancer... Read More
News From The Journal Of Clinical Investigation: Nov. 12, 2012
Nov 13, 2012
Home field advantage: Intravaginal immunization may help protect against infection Sexually-transmitted diseases (STDs) enter the body through the mucosal epithelial cells and the ability to direct pathogen-clearing T-cells to points of infection may be the critical element in developing successful vaccines against these infections... Read More
Added Benefit Of Ipilimumab In Advanced Melanoma
Nov 13, 2012
Advantages in overall survival, but disadvantages in the form of side effects The humanized antibody ipilimumab (trade name Yervoy®) has been approved since August 2011 for the treatment of adult patients with advanced melanoma (black skin cancer) who have already been treated... Read More
On The Hunt For Rare Cancer Cells
Nov 13, 2012
Jellyfish-inspired device that rapidly and efficiently captures cancer cells from blood samples could enable better patient monitoring. Tumor cells circulating in a patient's bloodstream can yield a great deal of information on how a tumor is responding to treatment and what drugs might be more effective against it... Read More
No Proof Of Added Benefit For Vandetanib In Thyroid Cancer
Nov 13, 2012
Vandetanib (trade name Caprelsa®) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG)... Read More
A New Approach To Combat Viral Infections
Nov 13, 2012
When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. Interferon can also play a role in suppressing tumor growth and the effects of autoimmune diseases, and doctors may use an artificial form of interferon to treat patients with certain cancers or multiple sclerosis... Read More
Previous Page Next Page